Assessment of Disease Burden and Palliative Care Needs of Patients During the Course of Incurable Cancer Disease
NCT ID: NCT02751723
Last Updated: 2019-03-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
500 participants
OBSERVATIONAL
2014-09-30
2019-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of a Patient Therapeutic Education Program in Improving Pain Management
NCT03297723
Patient-centred Integrated Palliative Care Pathways in Advanced Cancer and Chronic Disease
NCT02175147
Oral Care and Cancer: Assessing the Contribution of Training Healthcare Teams to Support the Oral Status of Patients Hospitalized in Palliative Situation
NCT02208908
Early Palliative Care on Quality of Life of Patients With Advanced Pancreas Cancer
NCT03837132
Holistic Needs Assessments in Patients With Melanoma
NCT06189261
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
lung cancer
validated questionnaires
validated questionnaires
malignant melanoma
validated questionnaires
validated questionnaires
cancer of the hepatobiliary system
validated questionnaires
validated questionnaires
head and neck cancer
validated questionnaires
validated questionnaires
breast cancer
validated questionnaires
validated questionnaires
ovarian carcinoma
validated questionnaires
validated questionnaires
pancreatic cancer
validated questionnaires
validated questionnaires
stomach cancer
validated questionnaires
validated questionnaires
oesophageal cancer
validated questionnaires
validated questionnaires
colorectal cancer
validated questionnaires
validated questionnaires
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
validated questionnaires
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* signed and dated Inform Consent Form
* Age ≥ 18 years
Exclusion Criteria
* Patient is in a critical health situation and is directly threatened due to cancer disease or the resulting complications
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Florian Lordick, MD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Florian Lordick, MD
Prof. Dr. med. (MD, PhD)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Florian Lordick, Prof. Dr.
Role: STUDY_CHAIR
University of Leipzig
Bend Alt-Epping, PD Dr.
Role: STUDY_CHAIR
University of Göttingen
Anja Mehnert, Prof. Dr.
Role: STUDY_CHAIR
University of Leipzig
Birgitt van Oorschot, Prof. Dr.
Role: STUDY_CHAIR
Comprehensive Cancer Centre Main-Franken, Würzburg
Michael Thomas, Prof. Dr.
Role: STUDY_CHAIR
Heidelberg University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UCCL, University of Leipzig
Leipzig, Saxony, Germany
Municipal Hospital Braunschweig
Braunschweig, , Germany
Internal medicine practice
Burgwedel, , Germany
Municipal Hospital Essen-Mitte
Essen, , Germany
University of Essen
Essen, , Germany
University of Göttingen
Göttingen, , Germany
University of Hamburg-Eppendorf
Hamburg, , Germany
Medical University Hanover
Hanover, , Germany
Clinic for Thoraric Diseases (Thoraxklinik)
Heidelberg, , Germany
Municipal Hospital Karlsruhe
Karlsruhe, , Germany
University of Leipzig, ENT
Leipzig, , Germany
Hospital Leverkusen
Leverkusen, , Germany
Municipal Hospital Magdeburg
Magdeburg, , Germany
University of Mainz
Mainz, , Germany
Maria Hilf Clinic
Mönchengladbach, , Germany
Radiotherapy practice
Recklinghausen, , Germany
University of Regensburg
Regensburg, , Germany
Hospital Südstadt Rostock
Rostock, , Germany
Immanuel Hospital Rüdersdorf
Rüdersdorf, , Germany
Hospital Traunstein
Traunstein, , Germany
Comprehensive Cancer Centre Main-Franken
Würzburg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DRKS00007536
Identifier Type: REGISTRY
Identifier Source: secondary_id
APM Project
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.